Low molecular weight peptides in gastroenterology: therapeutic potential
Abstrak
To evaluate the efficacy of peptide hydrolysates of animal and fish origin in reducing the severity of symptoms in patients with chronic diseases of the digestive system. Patients with chronic gastritis, chronic pancreatitis, gastroesophageal reflux disease, chronic constipation, intestinal malabsorption, multiple intestinal polyposis participated in the study. The prevalence of symptoms of the described diseases among participants was assessed before treatment and during one year of peptide hydrolysate supplementation. By the end of the course of monotherapy with peptide hydrolysates, the prevalence of all analysed symptoms of chronic digestive diseases was significantly lower compared to the pre-test results. The clinical effect in the majority of patients was achieved within the first 3–6 months of treatment.
Penulis (4)
V. Kovaleva
A. Malevanny
M. Krasovskaya
D. Mordvintsev
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →- Tahun Terbit
- 2025
- Bahasa
- en
- Sumber Database
- Semantic Scholar
- DOI
- 10.29296/25877305-2025-12-12
- Akses
- Open Access ✓